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INTRODUCTION 
Among the various infections caused by bacteria, 
antibiotic resistant ones are of major concern because of 
their non-responsiveness to treatment with a s ingle drug 
regimen thus resulting in therapeutic failure 
1
. The use of 
antibiotic combinations has been known since a long time 
and is often applied when several mechanis ms of action 
and toxicity profiles of the agents involved can be brought 
to halt at once 
2
. The biocidal (bactericidal, fungicidal or 
virucidal) activ ity could be best achieved by the 
combination of two different antibiotics rather than the 
effect obtained by an individual antibiotic 
3
. Combination 
of antibiotics is one such methodology and is applied only 
under certain circumstances. Although the combination of 
two or more antibiotics may not provide accurate control 
as observed in few cases, it can atleast delay the 
emergence of bacterial resistance 
4
. Synergistic 
combinations are often applied in situations of resistance 
development and when ineffectiveness of a single 
antibiotic are prevalent, in treatment of life threatening 
infections based completely on experimental terms, prior 
to the identification of the causal organism, prevention of 
bacterial resistance development and in the treatment of 
infections caused by a combination of microbes (bacteria)  
3
. Staphylococcus spp being well known for causing 
nosocomial infections, it could also lead to severe clinical 
manifestations like pneumonia, deep abscesses, 
osteomyelitis, endocarditis, phlebitis, arthritis, mastitis and 
meningitis, thus stressing the need for combination 
therapy.  It can also produce beta-lactamase enzyme which  
is capable of penicillin resistance 
5, 6
. Thus, there is a need 
to find new ways to control evolving of drug resistant S. 
aureus infections and embark on the need for a continued 
search of new methods for treatment with the application 
of combination therapy
 7
. 
Among the techniques employed in the evaluation of the 
combination of two antimicrobials potentially exh ibit ing 
synergism, is the checkerboard or fractional inhibitory  
concentration (FIC) technique. FIC employs a 
methodology similar to that utilized for the determination 
of the minimum inhib itory concentration (MIC). The 
combination is said to have synergistic effect if there is a 
4-fold reduction in the MIC of each antimicrobial agent 
tested alone 
2
.  Kanamycins are members of the 
aminoglycoside family having a broad spectrum of activity 
against many species of bacteria. Their mechanism of 
action is specific to aerobic, Gram negative bacteria 
however it can act synergistically against some Gram 
positive bacteria. Kanamycin main ly targets the proteins 
synthesis by irreversibly binding to the 16s rRNA of 30s 
ribosomal subunit. Binding of kanamycin to the decoding 
region of 3
’
end of rRNA prevents the tRNA from b inding 
to the ribosomal A-site thus bringing about translational 
errors 
8
. Ampicillin is a commonly used broad-spectrum 
aminopenicillin with known activ ity against E. coli and 
Staphylococcus aureus 
4
. These aminopenicillins inhibit  
the final stage of synthesis of cross- links of peptidoglycan 
which occurs outside the cell and is catalyzed by a 
transpeptidase 
1
. In this study, the interaction between 
ampicillin and kanamycin is investigated using the 
checkerboard method. The result of the study could 
provide rational basis for clinical use of these combination 
of antibiotics against infections caused by these drug 
resistant organisms. 
METHODS 
Materials:   
The culture media used in the study included Nutrient 
agar, Mueller-Hinton agar, Mueller-Hinton broth and 
Mannitol salt agar (all of them from Hi-Media). Ampicillin  
and Kanamycin were obtained from Hi-Media. Clinical 
isolates of microorganis ms were isolated fro m clinical 
samples. 
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Preparation of culture media:  
The culture media were prepared according to the 
manufacturers’ specificat ions. Initially they were weighed, 
dissolved in required amount of water and then sterilized  
by autoclaving at 121°C for 15 min.  
Isolation and confirmation of S.aureus:  
The clinical samples (50 samples) for the isolation of 
S.aureus were collected from various laboratories  of 
Bangalore during the period October 2011 to December 
2011. These isolates were init ially grown on nutrient agar. 
The colonies on nutrient agar were identified based on 
colony characteristics and Gram staining. Further 
characterizat ion was carried out by streaking the inoculum 
on selective media i.e., Mannitol salt agar. The organism 
was confirmed by performing b iochemical tests, most 
important of them are catalase and coagulase tests both of 
which gave positive results. The isolated and confirmed  
isolates were subcultured weekly on fresh nutrient agar 
slants and stored at 4°C 
3
. 24 hr fresh culture was obtained 
prior to each study. 
Antibiotic susceptibility test:  
Antimicrobial susceptibility was determined by Kirby- 
Bauer d isc diffusion technique. Antibiotic discs used in 
this investigation are standardized discs: Kanamycin  
(30mcg/disc), Chloramphenico l (30mcg/disc), Ampicillin  
(30mcg/disc), Vancomycin (30mcg/disc), Erythromycin  
(15mcg/disc) and Penicillin (10units/disc). Actively 
growing 16hr old culture was surface spread using sterile 
cotton swabs onto the Mueller-Hinton agar surface. The 
plates were kept aside for absorption for 15 min. The 
antibiotic discs were then placed onto the agar surface and 
the plates were incubated at 37
o
C for 16-18 hr. The plates 
were examined for the zone of inhibit ion around the 
antibiotic discs that would indicate the sensitivity of the 
organism 
1
.  
Preparation of antibiotic stock solution:  
Standard powder forms of Ampicillin and Kanamycin  
were stored at 2 to 8°C until use. The stock solution of 
Ampicillin and Kanamycin was prepared by weighing and 
subsequently dissolving appropriate quantities of the 
antibiotic in 50ml of Mueller- Hinton broth to obtain a 
concentration of 1000µg/ml of each antibiotic.  
Preparation of inoculum:  
The inoculum was obtained by transferring a small volume 
of stored culture to fresh media which was incubated 
overnight containing actively dividing cells. This was used 
for synergism test.   
Test for Synergism:  
Serial two fo ld dilut ions of each antibiotic stock to at least 
double the MIC were prepared. The first antibiotic of the 
combination was serially diluted along the ordinate while 
the second antibiotic was diluted along the abscissa 
9
. 
Varying concentrations of 2.5, 5.0, 10, 20, 40, 80, 160 and 
250µg/ml of each antibiotic was used for combination. A 
total of 2000µl of Mueller -Hinton broth was distributed 
into each 2.5ml screw cap tubes which also contained 
100µl of the bacterial culture. The tubes were incubated at 
37°C for 24 hr. The resulting checker board contains a 
combination of two antibiot ics, with the tubes that contain 
the highest concentration of each antibiotic at opposite 
corners 
9
.  
According to the NCCLS guidelines for broth 
microdilution, the MIC was defined as the lowest 
concentration of antibiotic that completely inhib ited the 
growth of the organism as observed detected with the 
naked eye. Synergy is more likely to be expressed when 
the ratio of the concentration of each antibiotic to the MIC 
of that antibiotic was same for all components of the 
mixture. Interaction was assessed algebraically by 
determining the fractional inhibitory concentration (FIC) 
indices. The FIC (Fract ional Inhibitory Concentration) 
were calculated as follows: FIC= FIC A+ FIC B, where 
FIC A is the MIC of antibiotics in combination/ MIC OF 
antibiotic A alone and FIC B is the MIC of antibiotics in 
combination/ MIC OF antibiotic B alone.  
RES ULTS         
The clinical samples were collected for the study from 
different laboratories 
6, 10
. A maximum of 36% clinical 
samples were obtained from wound and abbesses and post 
operative infections (POI) showed 21% followed by ulcer 
13% and boils 9%. Results show incidence of S. aureus 
infections (Fig 1). 
The disk diffusion test plates were examined for zone of 
inhibit ion around the antibiotic disks. Thus disk diffusion 
results indicate the mult i drug resistance pattern of 
Staphylococcus aureus. The development of resistance by 
S. aureus is an ever increasing problem.  Hence a 
combination of antibiot ics using checker board method 
gave better control against S.aureus 
11, 12
.  
In the Checkerboard technique, the interaction between 
combination of ampicillin and kanamycin against 
Staphylococcus aureus were predominantly synergistic 
with FIC index of 0.5625, although there were few 
variations. Thus no growth or turbidity clearly illustrated 
the extensive activity of aminoglycoside which was 
enforced by the second drug, ampicillin resulting in an 
antibacterial effect (Fig.2). FIC-index values less than 1 
were considered as synergy and the degree of synergy 
increases as the value tends towards zero. FIC-index value 
greater than one but less than two indicates indifference 
while FIC value greater than two represents antagonism. 
DISCUSS ION 
Goals of combination therapy are to obtain broad spectrum 
coverage, enhance antimicrobial activ ity through 
synergistic interaction and minimize resistance 
development for most infections. A combination therapy 
may be needed for treatment of mixed infections, when not 
all organisms are susceptible to the same antibiotic;  
prevention or delay of development of bacterial resistance 
to an antibiotic; ability to use non-toxic amounts of two 
antibiotics when toxic doses of a single antibiotic would be 
required and when combination therapy may be more 
effective against a single organism than the use of single 
antimicrobial agent.  
In this study the FIC-index for combination of ampicillin  
and kanamycin against S.aureus was found to be 0.5625 
indicating the synergistic effect of the combination, the 
FIC value being in agreement with the report of Nworu et  
al report (2006) the combination being ampicillin and 
ciprofloxacin. This report is also in contradiction with that 
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of Ibezim et al (2006) using ampicillin and cotrimoxazole 
combination. Th is is because the combination used could 
vary depending upon the strain of S.aureus, the 
environment in which they exist and several other 
conditions. The combination of two antibiotics exhib ited 
significant synergism, the mechanism involving the 
penetration of ampicillin into the peptidoglycan layer 
leading to cross-links and inhibition of cell wall synthesis 
and there by increases the permeability of the bacterium to 
kanamycin that binds to the 30s ribosome inhibit ing the 
protein synthesis 
13,14
. On the other hand the organism 
exhibited a higher MIC for one of the antibiotic alone and 
this is in support with the report of Sato et al (2004) 
15, 16
. 
It is hoped that these approaches, if well standardized and 
adopted, will not only provide useful alternatives to pre-
existing time-kill and checkerboard titration method, but 
will also circumvent problems and methodological 
limitat ions inherent in their use 
17, 18
.  
 
Figure 1: Incidence of infect ion by S.aureus in clinical 
samples 
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Figure 2: The synergistic effect of the two antib iotics 
against S. aureus 
CONCLUS ION 
Staphylococcus aureus, the ‘king of nosocomial infections’ 
is of major concern all over the globe because of the mult i-
antibiotic resistance pattern exhib ited by the organism. 
Although researchers are finding newer antibiotics for the 
control of ‘the nosocomial king’, its  multi-antibiotic 
resistance pattern still exists and hence synergistic effect of 
known antibiotics is the best tool that could be employed 
to control nosocomial infections caused by S. aureus. 
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